Skip to main content

Table 1 The relationship of MSI2 with ZEB1, E-cad, Vimentin and c-Myc expression in clinical samples

From: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling

Parameters CRT Spearman ranks P
Low (24) High (50)
ZEB1 Negative (35) 16 19 0.269 0.021
Positive (39) 8 31   
E-cad Abnormal (45) 10 35 −0.272 0.019
Normal (29) 14 15   
c-Myc Negative (36) 16 20 0.250 0.032
Positive (38) 8 30   
Vimentin Negative (52) 20 32 0.198 0.089
Positive (22) 4 18